1. Stanton JM . Weight gain associated with neuroleptic medication: a review. Schizophr Bull 1995; 21: 463–472.
2. National Heart, Lung, and Blood Institute. Obesity Education Initiative: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. US Department of Health and Human Services, 1998.
3. Falloon I, Watt DC, Shepherd M . A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia. Psychol Med 1978; 8: 59–70.
4. Jones B, Basson BR, Walker DJ, Crawford AM, Kinon BJ . Weight change and atypical antipsychotic treatment in patients with schizophrenia. J Clin Psychiatry 2001; 62 (Suppl 2): 41–44.
5. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156: 1686–1696.